Notably, tumor sideness had a minimal effect on the ICL/ICRs expression pattern (Supplementary Figure 3D), while the ICL/ICRs showed unique distribution patterns based on tumor KRAS/TP53 mutation status (Figure 3G). The gene discussed is TP53; the disease is neoplasm.